Situation
An international cerebrovascular/cardiovascular device company required support staffing field clinical specialists for a global clinical trial spanning North America, Europe, and South America. These specialists would play a critical role in training implanting physicians and providing procedural guidance during device implantation to ensure accurate deployment and optimal patient outcomes.
Given the novel nature of the technology, the sponsor needed highly skilled clinical experts capable of delivering consistent technical support across multiple geographies while maintaining the highest standards of patient safety and procedural success.
Solution
Drawing on more than 15 years of experience supporting medical device sponsors worldwide, HCC partnered closely with the client to define the specific clinical expertise, procedural experience, and interpersonal skills required for the role.
Leveraging its global network of CRO partners and clinical experts, HCC established an international proctoring team spanning three continents. Through a rigorous and collaborative selection process, HCC identified highly qualified field clinical specialists with the expertise needed to support physicians throughout the trial.
To ensure consistency across regions, HCC implemented comprehensive product training and standardized communication and procedural practices. The result was a coordinated global team capable of serving as a seamless extension of the sponsor's organization while providing localized clinical support at each study site.
Impact
The effectiveness of this approach was demonstrated from the outset, with the trial's first implant completed on schedule, per protocol, and with a successful patient outcome. HCC's proctor was actively involved throughout the process, from case screening and procedural planning to intraoperative support, helping ensure procedural confidence and successful device deployment.
By providing experienced local clinical specialists at sites around the world, HCC enabled consistent physician support while eliminating the need for extensive international travel by sponsor personnel. This localized model not only reduced logistical complexity and costs but also strengthened relationships with investigators and clinical teams, supporting the successful adoption of a breakthrough medical technology.
Want to learn more about HCC?
Get in touch with our team.
.avif)



